1-20 of 24
immunotherapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single- and double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM

Marietta S. Truger, Johannes Duell, Xiang Zhou, Larissa Heimeshoff, Anna Ruckdeschel, Mara John, Angela Riedel, Sebastian Hüper, Jessica Peter, Wencke Walter, Larissa Haertle, Manja Meggendorfer, Max S. Topp, Andreas Rosenwald, Matteo Claudio Da Via, Niccolo Bolli, Niels Weinhold, Hermann Einsele, Claudia Haferlach, K. Martin Kortüm, Leo Rasche
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3794–3798.
https://doi.org/10.1182/bloodadvances.2021004418
Published: 2021
Includes: Supplemental data
Journal Articles

The promise and perils of immunotherapy

Stefanie Lesch, Saar Gill
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3709–3725.
https://doi.org/10.1182/bloodadvances.2021004453
Published: 2021
Journal Articles

Involved-site radiotherapy for Helicobacter pylori –independent gastric MALT lymphoma: 26 years of experience with 178 patients

Clinical Trials & Observations
Joachim Yahalom, Amy J. Xu, Ariela Noy, Stephanie Lobaugh, Monica Chelius, Karen Chau, Carol Portlock, Carla Hajj, Brandon S. Imber, David J. Straus, Craig H. Moskowitz, Morton Coleman, Andrew D. Zelenetz, Zhigang Zhang, Ahmet Dogan
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1830–1836.
https://doi.org/10.1182/bloodadvances.2020003992
Published: 2021
Journal Articles

Immunotherapy perspectives in the new era of B-cell editing

Natsuko Ueda, Marine Cahen, Yannic Danger, Jérôme Moreaux, Christophe Sirac, Michel Cogné
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1770–1779.
https://doi.org/10.1182/bloodadvances.2020003792
Published: 2021
Journal Articles

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Catherine S. Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce Raphael, Tibor Moskovits, Kenneth Hymes, Jonas Schluter, J. Chen, N. Nora Bennani, Thomas E. Witzig, Jiyoung Ahn
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1194–1198.
https://doi.org/10.1182/bloodadvances.2020003129
Published: 2021
Includes: Supplemental data
Journal Articles

The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome

Iosifina P. Foskolou, Laura Barbieri, Aude Vernet, David Bargiela, Pedro P. Cunha, Pedro Velica, Eunyeong Suh, Sandra Pietsch, Rugile Matuleviciute, Helene Rundqvist, Dominick McIntyre, Ken G. C. Smith, Randall S. Johnson
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4483–4493.
https://doi.org/10.1182/bloodadvances.2020002309
Published: 2020
Includes: Supplemental data
Journal Articles

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas

Alexander Neuwelt, Taha Al-Juhaishi, Eduardo Davila, Bradley Haverkos
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4256–4266.
https://doi.org/10.1182/bloodadvances.2020001966
Published: 2020
Journal Articles

Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia

Clinical Trials & Observations
Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Jonathan R. Fromm, Mary-Elizabeth M. Percival, Cameron J. Turtle, Paul T. Nghiem, Phillip A. Stevenson, Elihu H. Estey
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3239–3245.
https://doi.org/10.1182/bloodadvances.2020002403
Published: 2020
Includes: Supplemental data
Journal Articles

CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma

Poornima Ramkumar, Anthony B. Abarientos, Ruilin Tian, Meghan Seyler, Jaime T. Leong, Merissa Chen, Priya Choudhry, Torsten Hechler, Nina Shah, Sandy W. Wong, Thomas G. Martin, III, Jeffrey L. Wolf, Kole T. Roybal, Andreas Pahl, Jack Taunton, Arun P. Wiita, Martin Kampmann
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2899–2911.
https://doi.org/10.1182/bloodadvances.2019001346
Published: 2020
Includes: Supplemental data
Journal Articles

Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma

Aishwarya Iyer, Dylan Hennessey, Sandra O’Keefe, Jordan Patterson, Weiwei Wang, Gane Ka-Shu Wong, Robert Gniadecki
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2489–2500.
https://doi.org/10.1182/bloodadvances.2020001441
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement

Clinical Trials & Observations
Valentina Nardi, Nora Ku, Matthew J. Frigault, Adrian M. Dubuc, Harrison Kwei Tsai, Philip C. Amrein, Gabriela S. Hobbs, Andrew M. Brunner, Rupa Narayan, Meghan E. Burke, Julia Foster, Paola Dal Cin, Marcela V. Maus, Amir T. Fathi, Hanno Hock
Journal: Blood Advances
Blood Adv (2020) 4 (1): 106–111.
https://doi.org/10.1182/bloodadvances.2019000769
Published: 2020
Includes: Supplemental data
Journal Articles

Opportunities for immunotherapy in childhood acute myeloid leukemia

Adam J. Lamble, Sarah K. Tasian
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3750–3758.
https://doi.org/10.1182/bloodadvances.2019000357
Published: 2019
Journal Articles

Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy

Joshua A. Hill, Elizabeth M. Krantz, Kevin A. Hay, Sayan Dasgupta, Terry Stevens-Ayers, Rachel A. Bender Ignacio, Merav Bar, Joyce Maalouf, Sindhu Cherian, Xueyan Chen, Greg Pepper, Stanley R. Riddell, David G. Maloney, Michael J. Boeckh, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3590–3601.
https://doi.org/10.1182/bloodadvances.2019000717
Published: 2019
Includes: Supplemental data
Journal Articles

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Max Jan, Matthew J. Leventhal, Elizabeth A. Morgan, Jordan C. Wengrod, Anwesha Nag, Samantha D. Drinan, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Scott Leppanen, Jane Baronas, Jonathan Stevens, William J. Lane, Natasha Kekre, Vincent T. Ho, John Koreth, Corey S. Cutler, Sarah Nikiforow, Edwin P. Alyea, III, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, R. Coleman Lindsley, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2199–2204.
https://doi.org/10.1182/bloodadvances.2019000445
Published: 2019
Includes: Supplemental data
Journal Articles

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Chandini M. Thirukkumaran, Zhong Qiao Shi, Gerard J. Nuovo, Joanne Luider, Karen A. Kopciuk, Yuan Dong, Ahmed A. Mostafa, Satbir Thakur, Kathy Gratton, Ailian Yang, Alex C. Chin, Matt C. Coffey, Victor H. Jimenez-Zepeda, Douglas Stewart, Marta Chesi, P. Leif Bergsagel, Don Morris
Journal: Blood Advances
Blood Adv (2019) 3 (5): 797–812.
https://doi.org/10.1182/bloodadvances.2018025593
Published: 2019
Includes: Supplemental data
Journal Articles

Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR

Clinical Trials & Observations
Duncan Murray, Jack Luke McMurray, Suzy Eldershaw, Hayden Pearce, Nathaniel Davies, Julia J. Scarisbrick, Paul Moss
Journal: Blood Advances
Blood Adv (2019) 3 (4): 519–530.
https://doi.org/10.1182/bloodadvances.2018025114
Published: 2019
Includes: Supplemental data
Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Clinical Trials & Observations
Tania Jain, Mark R. Litzow
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3393–3403.
https://doi.org/10.1182/bloodadvances.2018020198
Published: 2018
Journal Articles

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

Adrienne Sallets, Sophie Robinson, Adel Kardosh, Ronald Levy
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2230–2241.
https://doi.org/10.1182/bloodadvances.2018020040
Published: 2018
Includes: Supplemental data
Journal Articles

Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens

Jefferson L. Lansford, Udara Dharmasiri, Shengjie Chai, Sally A. Hunsucker, Dante S. Bortone, James E. Keating, Ian M. Schlup, Gary L. Glish, Edward J. Collins, Gheath Alatrash, Jeffrey J. Molldrem, Paul M. Armistead, Benjamin G. Vincent
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2052–2062.
https://doi.org/10.1182/bloodadvances.2018022475
Published: 2018
Includes: Supplemental data
Journal Articles

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

Clinical Trials & Observations
Peter G. Maslak, Tao Dao, Yvette Bernal, Suzanne M. Chanel, Rong Zhang, Mark Frattini, Todd Rosenblat, Joseph G. Jurcic, Renier J. Brentjens, Maria E. Arcila, Raajit Rampal, Jae H. Park, Dan Douer, Laura Katz, Nicholas Sarlis, Martin S. Tallman, David A. Scheinberg
Journal: Blood Advances
Blood Adv (2018) 2 (3): 224–234.
https://doi.org/10.1182/bloodadvances.2017014175
Published: 2018
Includes: Supplemental data